Search Results - Jason Chang
Jason Chang
Jason Chang Chien-Sheng (; born 18 May 1944) is a Taiwanese-Singaporean billionaire, and the chairman of Taiwan-based Advanced Semiconductor Engineering (ASE). On the ''Forbes'' 2024 list of the world's billionaires, he was ranked #417 with a net worth of US$6.6 billion.In September 2015, Chang received a Semiconductor Equipment and Materials International SEMI Award, which recognized his "significant achievements in the development and commercialization of copper wire in the IC assembly process". Provided by Wikipedia
- Showing 1 - 6 results of 6
-
1
-
2
Evaluation of the predictive ability of ultrasound-based assessment of breast cancer using BI-RADS natural language reporting against commercial transcriptome-based tests. by Neema Jamshidii, Jason Chang, Kyle Mock, Brian Nguyen, Christine Dauphine, Michael D Kuo
Published in PLoS ONE (2020-01-01)Get full text
Article -
3
The Renin–Angiotensin System Modulates SARS-CoV-2 Entry via ACE2 Receptor by Sophia Gagliardi, Tristan Hotchkin, Hasset Tibebe, Grace Hillmer, Dacia Marquez, Coco Izumi, Jason Chang, Alexander Diggs, Jiro Ezaki, Yuichiro J. Suzuki, Taisuke Izumi
Published in Viruses (2025-07-01)Get full text
Article -
4
Endoscopic sleeve gastroplasty using the novel single‐channel suturing device: A multicenter experience by Ravishankar Asokkumar, Rajesh Ravi, Voraboot Taweerutchana, Yu Bin Tan, Kotchakorn Maipang, Lim Chin Hong, Nicha Srisuworanan, Lee Phong Ching, Christopher Khor, Jason Chang, Nonthalee Pausawasdi
Published in DEN Open (2023-04-01)Get full text
Article -
5
Follicular helper T cells promote liver pathology in mice during Schistosoma japonicum infection. by Xiaojun Chen, Xiaowei Yang, Yong Li, Jifeng Zhu, Sha Zhou, Zhipeng Xu, Lei He, Xue Xue, Weiwei Zhang, Xiaoxiao Dong, Henry Wu, Carrie J Li, Hsiang-Ting Hsu, Wenjun Kong, Feng Liu, Prem B Tripathi, Michelle S Yu, Jason Chang, Liang Zhou, Chuan Su
Published in PLoS Pathogens (2014-05-01)Get full text
Article -
6
Responsiveness of different MET tumour alterations to type I and type II MET inhibitors by Yonina R. Murciano‐Goroff, Valentina Foglizzo, Jason Chang, Natasha Rekhtman, Ann Elizabeth Sisk, Jamie Gibson, Lia Judka, Kristen Clemens, Paola Roa, Shaza Sayed Ahmed, Nicole V. Bremer, Courtney Lynn Binaco, Sherifah Kemigisha Muzungu, Estelamari Rodriguez, Madeline Merrill, Erica Sgroe, Matteo Repetto, Zsofia K. Stadler, Michael F. Berger, Helena A. Yu, Eneda Toska, Srinivasaraghavan Kannan, Chandra S. Verma, Alexander Drilon, Emiliano Cocco
Published in Clinical and Translational Medicine (2025-05-01)Get full text
Article
